FDA permits emergency use of flu drugs, diagnostic test:

04/27/2009 | Reuters · Wall Street Journal, The

The FDA has signed emergency authorizations for unapproved uses of GlaxoSmithKline's Relenza, Roche Holding's Tamiflu and the rRT-PCR Swine Flu Panel diagnostic test in response to the public health emergency declared amid the swine flu outbreak. The swine flu strain reportedly has infected more than 40 people in the U.S.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA